Panacela Labs

About:

Panacela Labs is a clinical-stage biotechnology company focusing on oncology and orphan drug development.

Top Investors: Cleveland BioLabs, RUSNANO

Description:

Panacela Labs, Inc. is a joint venture company founded in 2011 by Cleveland BioLabs (Nasdaq:CBLI), a clinical-stage biotechnology company with a focus on oncology and orphan drug development, and Open Joint Stock Company “RUSNANO”, the largest Russian investment company, in collaboration with Roswell Park Cancer Institute, Children’s Cancer Institute of Australia and Cleveland Clinic Foundation. Panacela Labs is 54.6% owned by Cleveland BioLabs. Panacela Labs has residency in the Innovation Center "Skolkovo".

Total Funding Amount:

$39.9M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

New York, New York, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)panacelalabs.com

Founders:

Number of Employees:

1-10

Last Funding Date:

2015-12-24

IPO Status:

Private

Industries: